Cranbrook Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14
Closed -$331 302
2022
Q4
$331 Hold
14
﹤0.01% 283
2022
Q3
$0 Hold
14
﹤0.01% 317
2022
Q2
$0 Hold
14
﹤0.01% 342
2022
Q1
$1K Hold
14
﹤0.01% 340
2021
Q4
$1K Hold
14
﹤0.01% 350
2021
Q3
$2K Buy
+14
New +$2.04K ﹤0.01% 411

Other funds holding TDOC

Cranbrook Wealth Management's TDOC Position: Q1 2023 in Review

Cranbrook Wealth Management sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 14 shares — an estimated $331 sold.

Cranbrook Wealth Management first reported a position in TDOC in Q3 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2021. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Cranbrook Wealth Management reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Cranbrook Wealth Management sold 14 Teladoc Health shares in Q1 2023, an estimated $331.
  • Cranbrook Wealth Management first reported a position in Teladoc Health in Q3 2021 and held it in 6 quarters.
  • Cranbrook Wealth Management's Teladoc Health position peaked at $2K in Q3 2021.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Cranbrook Wealth Management's 13F filing for Q1 2023, filed 20 Apr 2023.